Concern about overnight hypoglycemic events drives decision-making for patients with type 1 diabetes. For persons with type 1 diabetes (T1D) fear of the overnight hypoglycemic event drives care ...

Recent reports have shown that Gilead's ($GILD) hep C superstars, Sovaldi and Harvoni, are linked to fewer serious side effects than AbbVie's ($ABBV) rival med ...

Statins are tried-and-true moneymakers, but they also come with their own set of safety concerns. Cardiovascular problems linked to the meds are nothing new, and scientists recently highlighted ...

In January 2015 Advera Health released a Drug Safety Monitor analysis comparing the safety of then newly-approved Hepatitis C drugs Viekira Pak to Harvoni and Solvaldi (hereafter just Harvoni). Our ...

A review of evidence of the clinical safety and efficacy of Zepatier found that the hepatitis C virus treatment appears to have a less risky safety profile than Sovaldi and a similar safety profile as ...

There is no "good medicine" for everyone — drugs react differently in different people. At best, drug development is a game of clinically tested hedges by companies, doctors, insurers and regulators ...

TriNetX, which focuses on real-world research to help develop new therapies, acquired pharmacovigilance software maker Advera Health Analytics for an undisclosed price. With the deal, TriNetX gets ...

He’s tan and athletic, with a model’s good looks – and, the ad that features him says, infected with the virus that causes AIDS. He’s the Advera man, spokesman for a new advertising campaign. Advera, ...

He’s tanned and athletic, with a model’s good looks-and, the ad that features him says, infected with the virus that causes AIDS. He’s the Advera man, spokesman for a controversial new advertising ...

In January 2015, Advera Health released a Drug Safety Monitor analysis comparing the safety of then newly approved Hepatitis C drugs Viekira Pak to Harvoni and Solvaldi (hereafter just Harvoni). Our ...